• Shashikant Shetty
  • Anshulee Sood
Part of the Current Practices in Ophthalmology book series (CUPROP)


Nystagmus can be a physiological response or the sign of a serious underlying disease. It is an extremely complex spectrum of motility abnormalities, and both experience and skill are needed to decipher it completely. This chapter introduces the reader to the various forms of nystagmus, beginning with physiological nystagmus. Congenital nystagmus and its various forms are described in detail—the newer nomenclature for this entity has also been included. Acquired varieties of nystagmus such as downbeat and upbeat nystagmus and vestibular nystagmus are discussed along with other more rare variants such as see-saw nystagmus. Other related motility abnormalities such as opsoclonus, flutter, saccadic intrusions, and square-wave jerks are also explained. A brief account of the clinical examination including pertinent tests is described. Management of nystagmus has also been included.


Physiological nystagmus Infantile nystagmus syndrome Fusion maldevelopment nystagmus Spasmus nutans See-saw nystagmus PAN 


  1. 1.
    Sarvananthan N, Surendran M, Roberts EO, Jain S, Thomas S, Shah N, et al. The prevalence of nystagmus: the Leicestershire nystagmus survey. Invest Ophthalmol Vis Sci. 2009;50(11):5201–6.CrossRefGoogle Scholar
  2. 2.
    Spielmann A. Clinical rationale for manifest congenital nystagmus surgery. J AAPOS. 2000;4(2):67–74.CrossRefGoogle Scholar
  3. 3.
    Abadi RV, Bjerre A. Motor and sensory characteristics of infantile nystagmus. Br J Ophthalmol. 2002;86:1152–60.CrossRefGoogle Scholar
  4. 4.
    Leigh RJ, Rucker JC. Nystagmus and related ocular motility disorders. In: Miller NR, Newman NJ, editors. Walsh & Hoyt’s clinical neuro-ophthalmology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1133–73.Google Scholar
  5. 5.
    Brodsky MC, et al. Nystagmus in infancy and childhood. In: Brodsky MC, Baker RS, Hamed LM, editors. Pediatric neuroophthalmology. New York: Springer; 1996. p. 302–47.Google Scholar
  6. 6.
    Von Noorden GK. The nystagmus blockage syndrome. Trans Am Ophthalmol Soc. 1976;74:220–36.Google Scholar
  7. 7.
    Tychsen L, et al. The neural mechanism for latent (fusion maldevelopment) nystagmus. J Neuroophthalmol. 2010;30:276–83.CrossRefGoogle Scholar
  8. 8.
    Thurtell MJ, Leigh RJ. Nystagmus and saccadic intrusions. Handb Clin Neurol. 2011;102:333–78.CrossRefGoogle Scholar
  9. 9.
    Wagner JN, Glaser M, Brandt T, Strupp M. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry. 2008;79(6):672–7.CrossRefGoogle Scholar
  10. 10.
    Claassen J, Spiegel R, Kalla R, et al. A randomized double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus V effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry. 2013;84(12):1392–9.CrossRefGoogle Scholar
  11. 11.
    Claassen J, Feil K, Bardins S, et al. Dalfampridine in patients with downbeat nystagmus V an observational study. J Neurol. 2013;260(8):1992–6.CrossRefGoogle Scholar
  12. 12.
    Thurtell MJ, Leigh RJ. Therapy for nystagmus. J Neuroophthalmol. 2010;30(4):361–71.CrossRefGoogle Scholar
  13. 13.
    Thurtell MJ, Joshi AC, Leone AC, et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol. 2010;67(5):676–80.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Glasauer S, Kalla R, Buttner U, et al. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry. 2005;76(3):451–3.CrossRefGoogle Scholar
  15. 15.
    Dieterich M, Straube A, Brandt T, et al. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry. 1991;54(7):627–32.CrossRefGoogle Scholar
  16. 16.
    Baloh RW, Honrubia V, Konrad HR. Periodic alternating nystagmus. Brain. 1976;99(1):11–26.CrossRefGoogle Scholar
  17. 17.
    Leigh RJ, Robinson DA, Zee DS. A hypothetical explanation for periodic alternating nystagmus: instability in the optokinetic-vestibular system. Ann N Y Acad Sci. 1981;374:619–35.CrossRefGoogle Scholar
  18. 18.
    Serra A, Liao K, Martinez-Conde S, et al. Suppression of saccadic intrusions in hereditary ataxia by memantine. Neurology. 2008;70(10):810–2.CrossRefGoogle Scholar
  19. 19.
    Thurtell MJ, Rucker JC, Tomsak RL, Leigh RJ. Medical treatment of acquired nystagmus. Expert Rev Ophthalmol. 2011;6:307–14.CrossRefGoogle Scholar
  20. 20.
    Hertle RW, Yang D, Adkinson T, et al. Topical brinzolamide (Azopt) versus placebo in the treatment of infantile nystagmus syndrome (INS). Br J Ophthalmol. 2015;99:471–6.CrossRefGoogle Scholar
  21. 21.
    Dell’osso LF, et al. Effects of topical brinzolamide on infantile nystagmus syndrome waveforms: eyedrops for nystagmus. J Neuroophthalmol. 2011;31(3):228–33.PubMedGoogle Scholar
  22. 22.
    Hertle RW. Examination and refractive management of patients with nystagmus. Surv Ophthalmol. 2000;45:215–22.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Shashikant Shetty
    • 1
  • Anshulee Sood
    • 2
  1. 1.Paediatric Ophthalmology DepartmentAravind Eye HospitalMaduraiIndia
  2. 2.Tejas Eye HospitalMandviIndia

Personalised recommendations